The global Blood Collection Devices Market is poised for steady growth from 2025 to 2033, driven by the rising prevalence of chronic diseases, increasing demand for diagnostic testing, expanding blood donation activities, and continuous advancements in safe and minimally invasive blood collection technologies. The market is estimated to be valued at approximately USD 9.6 billion...
The Poultry Diagnostic Testing Market is poised for robust growth from 2025 to 2033, driven by the increasing need to prevent poultry disease outbreaks, improve flock health, strengthen food safety, and support efficient poultry production worldwide. The market is projected to be valued at approximately USD 675.3 million in 2025 and is forecasted to reach nearly USD 1,090.4 million by 2033,...
The Global Companion Animal Diagnostic Services Market is projected to reach USD 15.7 billion by 2033, from USD 8.9 billion in 2025, growing at a CAGR of 7.6% during the forecast period. The market is witnessing robust growth driven by increasing pet ownership, rising expenditure on animal healthcare, growing awareness of preventive veterinary care, and advancements in diagnostic technologies....
The global Chromatography Reagents Market is projected to witness robust growth from 2025 to 2033, driven by the rising demand for biopharmaceutical products, increasing pharmaceutical research and development activities, stringent regulatory requirements for drug quality, and growing applications of chromatography in food, environmental, and chemical testing. Valued at approximately USD 8.9...
The global Biobanking Market is experiencing significant growth, driven by the rising demand for personalized medicine, advancements in genomic research, and the expanding use of biological samples in drug discovery and clinical research. Valued at approximately USD 65.6 billion in 2025, the market is projected to reach USD 105.0 billion by 2033, expanding at a CAGR of 6.1% during the...
The global Liquid Biopsy Market is experiencing rapid growth, driven by the increasing demand for non-invasive cancer diagnostics, rising cancer incidence, and growing adoption of precision medicine. The market is projected to grow from approximately USD 15.9 billion in 2025 to USD 61.1 billion by 2033, registering a CAGR of 19.1% during the forecast period. Liquid biopsy is an...
The global Liquid Biopsy Market is experiencing rapid growth, driven by the increasing demand for non-invasive cancer diagnostics, rising cancer incidence, and growing adoption of precision medicine. The market is projected to grow from approximately USD 15.9 billion in 2025 to USD 61.1 billion by 2033, registering a CAGR of 19.1% during the forecast period. Liquid biopsy is an...
The global Next Generation Sequencing (NGS) Market is experiencing significant growth, driven by the increasing demand for rapid, accurate, and cost-effective genomic analysis technologies. Valued at approximately USD 20.17 billion in 2025, the market is projected to expand substantially through 2033. The growing adoption of NGS across clinical diagnostics, pharmaceutical research,...
The Hospital Acquired Infections Diagnostics Market is projected to witness significant growth between 2025 and 2035, driven by the increasing prevalence of healthcare-associated infections, rising antibiotic resistance, growing patient safety concerns, and the need for rapid and accurate infection detection. According to M2Square Consultancy, the market was valued at...
The global Oncology Drugs Market is anticipated to experience substantial growth from 2025 to 2033, driven by the rising global burden of cancer, increasing healthcare expenditure, advancements in precision medicine, and growing adoption of targeted therapies and immunotherapies. With an estimated valuation of approximately USD 253.6 billion in 2025, the market is expected to...
The global STD Diagnostics Market is anticipated to experience significant growth from 2025 to 2033, driven by the increasing prevalence of sexually transmitted diseases, growing public awareness, and continuous advancements in diagnostic technologies. The market is projected to reach approximately USD 8.5 billion in 2025 and is expected to expand to around USD 16.8 billion by 2033,...
The global infectious disease molecular diagnostics market is expected to witness steady growth as healthcare systems increasingly adopt advanced diagnostic technologies for accurate and early disease detection. According to Straits Research, the global infectious disease molecular diagnostics market size was valued at USD 42.88 billion in 2025 and is projected to grow from USD 45.66 billion in...
